| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |